Clinuvel Pharmaceuticals Limited (ASX:CUV)
Pharmaceuticals, Biotechnology & Life Sciences
Clinuvel Pharmaceuticals Limited (ASX:CUV) is a global biopharmaceuticals company with a focus on developing and delivering treatments for patients with a range of severe genetic and skin disorders. Clinuvel’s main product is called SCENESSE, which it develops and self-distributes.
Clinuvel Pharmaceuticals Limited (ASX:CUV) share price
Clinuvel Pharmaceuticals Limited (ASX:CUV) passive income
Clinuvel Pharmaceuticals Limited (ASX:CUV) share price news
Today's ASX news
Clinuvel (CUV) Shares Give Back Returns
The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price was trading 5% lower today. Over the past month, shares of Clinuvel Pharmaceuticals Limited are down 5%.
September 25, 2019
Today's ASX news
Clinuvel (CUV) Shares Boosted By Board Appointment
The Clinuvel Pharmaceuticals Limited (ASX:CUV) share price had lifted 4.8% higher today as the broader S&P/ASX 200 (INDEXASX:XJO) was mostly flat.
September 24, 2019
Today's ASX news
ALL ORDINARIES Index (XAO) Down, CBA (ASX:CBA) Share Price Drops
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.18% at lunch.
July 9, 2019
ASX Share Ideas
Is It Too Late To Buy Clinuvel Pharmaceuticals (CUV) Shares?
Clinuvel Pharmaceuticals Limited (ASX:CUV) shares are up nearly 90% year-to-date and 200% over the last 12 months. Is it too late to buy?
July 9, 2019
Today's ASX news
Afterpay (ASX:APT) To Enter The ASX 100
One of the changes in the S&P Dow Jones Indices rebalancing is that Afterpay Touch Group Ltd (ASX:APT) is entering the ASX 100.
June 14, 2019